Point72 Asset Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.5M Buy
1,952,234
+1,756,516
+897% +$14M 0.02% 882
2025
Q4
$1.18M Buy
+195,718
New +$1.17M ﹤0.01% 2783
2025
Q1
Sell
-848,454
Closed -$6.23M 2572
2024
Q4
$6.23M Buy
848,454
+843,239
+16,169% +$6.65M 0.01% 877
2024
Q3
$39.1K Sell
5,215
-12,385
-70% -$108K ﹤0.01% 1914
2024
Q2
$157K Sell
17,600
-14,900
-46% -$143K ﹤0.01% 1653
2024
Q1
$329K Buy
32,500
+24,500
+306% +$250K ﹤0.01% 1760
2023
Q4
$80.5K Buy
8,000
+4,900
+158% +$44.8K ﹤0.01% 1963
2023
Q3
$29K Sell
3,100
-508,500
-99% -$7.25M ﹤0.01% 2236
2023
Q2
$12.5M Sell
511,600
-1,171,500
-70% -$29.4M 0.04% 520
2023
Q1
$39.2M Buy
+1,683,100
New +$43M 0.12% 209
2022
Q4
Sell
-54,496
Closed -$1.05M 1809
2022
Q3
$1.05M Buy
+54,496
New +$1.39M ﹤0.01% 1046
2022
Q1
Sell
-2,055,100
Closed -$86M 1409
2021
Q4
$86M Buy
2,055,100
+2,033,400
+9,371% +$79.7M 0.34% 58
2021
Q3
$944K Buy
+21,700
New +$939K ﹤0.01% 867

Other funds holding VIR